Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
16.14
-0.13 (-0.80%)
Jun 11, 2026, 12:52 PM EDT - Market open
Sotera Health Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,189 | 1,164 | 1,100 | 1,049 | 1,004 | 931.48 | |
Revenue Growth (YoY) | 7.44% | 5.74% | 4.88% | 4.54% | 7.75% | 13.85% |
Cost of Revenue | 531.97 | 518.08 | 498.15 | 472.13 | 446.68 | 412.81 |
Gross Profit | 657.17 | 645.53 | 602.3 | 577.16 | 557 | 518.67 |
Selling, General & Admin | 257.91 | 252.76 | 242.63 | 236.67 | 245.71 | 198.16 |
Depreciation & Amortization Expenses | 18.44 | 30.74 | 62.04 | 63.8 | 62.94 | 63.78 |
Total Operating Expenses | 276.35 | 283.5 | 304.67 | 300.47 | 308.65 | 261.94 |
Operating Income | 380.82 | 362.03 | 297.63 | 276.69 | 248.35 | 256.73 |
Interest Expense | -149.59 | -155.72 | -164.69 | -142.88 | -80.14 | -74.19 |
Other Non-Operating Income (Expense) | -26.28 | -58.81 | -19.06 | -27.79 | -411.32 | -6.83 |
Total Non-Operating Income (Expense) | -175.88 | -214.53 | -183.75 | -170.67 | -491.46 | -81.02 |
Pretax Income | 204.94 | 147.51 | 113.87 | 106.03 | -243.11 | 175.72 |
Provision for Income Taxes | 87.14 | 69.56 | 69.48 | 54.65 | -9.54 | 58.6 |
Net Income | 117.8 | 77.95 | 44.4 | 51.38 | -233.57 | 117.12 |
Minority Interest in Earnings | - | - | - | - | - | 0.24 |
Net Income to Common | 117.8 | 77.95 | 44.4 | 51.38 | -233.57 | 116.88 |
Net Income Growth | 374.71% | 75.57% | -13.58% | - | - | - |
Shares Outstanding (Basic) | 284 | 284 | 283 | 281 | 280 | 279 |
Shares Outstanding (Diluted) | 287 | 286 | 285 | 283 | 280 | 279 |
Shares Change (YoY) | 0.72% | 0.53% | 0.60% | 1.12% | 0.26% | 17.54% |
EPS (Basic) | 0.41 | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
EPS (Diluted) | 0.41 | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
EPS Growth | 412.50% | 68.75% | -11.11% | - | - | - |
Free Cash Flow | 96.84 | 149.18 | 45.09 | -362.71 | 95.58 | 179.38 |
Free Cash Flow Growth | -35.08% | 230.81% | - | - | -46.72% | 167.42% |
Free Cash Flow Per Share | 0.34 | 0.52 | 0.16 | -1.28 | 0.34 | 0.64 |
Gross Margin | 55.26% | 55.48% | 54.73% | 55.00% | 55.50% | 55.68% |
Operating Margin | 32.02% | 31.11% | 27.05% | 26.37% | 24.74% | 27.56% |
Profit Margin | 9.91% | 6.70% | 4.03% | 4.90% | -23.27% | 12.57% |
FCF Margin | 8.14% | 12.82% | 4.10% | -34.57% | 9.52% | 19.26% |
EBITDA | 507.53 | 498.74 | 461.26 | 434.62 | 393.9 | 407.64 |
EBITDA Margin | 42.68% | 42.86% | 41.92% | 41.42% | 39.25% | 43.76% |
EBIT | 380.82 | 362.03 | 297.63 | 276.69 | 248.35 | 256.73 |
EBIT Margin | 32.02% | 31.11% | 27.05% | 26.37% | 24.74% | 27.56% |
Effective Tax Rate | 42.52% | 47.16% | 61.01% | 51.54% | 3.92% | 33.35% |